Status:
COMPLETED
A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate
Lead Sponsor:
DMF Medical Incorporated
Conditions:
End Tidal CO2
CO2 Removal
Eligibility:
All Genders
Phase:
NA
Brief Summary
CO2 removal is a mandatory part of modern anesthesia systems. Current chemical absorbers pose problems as the chemical granulate reacts not only with the CO2 but also the anesthetic drugs, producing o...
Detailed Description
CO2 removal is a mandatory part of modern anesthesia systems. Current chemical absorbers pose problems as the chemical granulate reacts not only with the CO2 but also the anesthetic drugs, producing o...
Eligibility Criteria
Inclusion
- American Society of Anesthesiology Physical Status Class I, II, III (low-medium risk patient)
- English-speaking patients
- Scheduled for elective surgery
- Length of anesthesia ≥ 60 minutes
Exclusion
- Pregnant
- American Society of Anesthesiology Physical Status Class IV (high risk patient)
- Patients schedule for emergency surgery
- Known respiratory disease, including COPD and severe asthma
- Have elevated pressure in your brain (intra cranial pressure, ICP)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02195245
Start Date
August 1 2014
End Date
October 1 2014
Last Update
October 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth II HSC, Halifax Infirmary Site
Halifax, Nova Scotia, Canada, B3H 3A7